Orgenesis Inc.
ORGSDelisted May 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001460602
Orgenesis Inc. was delisted on May 8, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 1 institution reported holding it in 13F filings for Q1 2025, worth $124.0K in total; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding Orgenesis Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 12 | 1 | −11 |
| Shares | 215.0K | 50.6K | −164.3K (−76.4%) |
| Value | $958.5K | $95.7K | −$862.8K (−90.0%) |
New holders (0)
Institutions that held Orgenesis Inc. at the end of Q4 2024 but not at the end of Q3 2024.
None.
Sold out (11)
Institutions that held Orgenesis Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Vanguard Group Inc | 91,023 | $406.0K |
| Geode Capital Management, LLC | 38,037 | $169.7K |
| Advisor Group Holdings, Inc. | 10,000 | $44.6K |
| BlackRock, Inc. | 5,961 | $26.6K |
| UBS Group AG | 4,743 | $21.2K |
| Tower Research Capital LLC (TRC) | 1,471 | $6.56K |
| Citigroup Inc | 126 | $562 |
| Bank of America Corp | 53 | $236 |
| JPMorgan Chase & Co | 9 | $40 |
| BNP Paribas Arbitrage, SA | 7 | $31 |
| Simplex Trading, LLC | 48 | $0 |